Regulatory services

  • Investigator's brochure
  • IMP dossier
  • CTA application & amendments
  • Post-approval reporting – as for Ethics
  • Regulatory advice:
    • protocol
    • amendments
    • pharmacovigilance
    • serious breaches of GCP